cloprostenol and Choroid-Diseases

cloprostenol has been researched along with Choroid-Diseases* in 4 studies

Other Studies

4 other study(ies) available for cloprostenol and Choroid-Diseases

ArticleYear
Bilateral choroidal effusion after selective laser trabeculoplasty.
    Archivos de la Sociedad Espanola de Oftalmologia, 2017, Volume: 92, Issue:6

    Selective laser trabeculoplasty (SLT) is an effective treatment to treat open-angle glaucoma with a low risk of complications. The case is presented of a 73 year-old woman with uncontrolled primary open-angle glaucoma who underwent selective laser trabeculoplasty in both eyes and developed bilateral choroidal effusion.

    Topics: Aged; Amides; Brimonidine Tartrate; Choroid Diseases; Cloprostenol; Combined Modality Therapy; Drug Combinations; Emergencies; Exudates and Transudates; Female; Glaucoma, Open-Angle; Humans; Laser Therapy; Timolol; Trabeculectomy

2017
[Massive choroidal detachment secondary to topical use of bimatoprost: Report of two cases].
    Journal francais d'ophtalmologie, 2012, Volume: 35, Issue:3

    To report two cases of choroidal detachment induced by topical bimatoprost.. Two males, aged 95 (case 1) and 74 years (case 2), were referred to our department for massive choroidal detachment. Case 1 was a one-eyed patient, and the affected eye of case 2 had undergone trabeculectomy 2 years previously. Both affected eyes were pseudophakic and treated for 6 months with topical bimatoprost/timolol fixed combination for open angle glaucoma (case 1) and pseudoexfoliation glaucoma (case 2). In both cases, symptoms appeared immediately after starting the drops and progressively worsened thereafter. In both affected eyes, moderate conjunctival hyperemia was noted, anterior segment examination and intraocular pressure were normal, and fundus examination revealed a massive choroidal detachment. This diagnosis was confirmed by B-scan ultrasonography. An adverse effect of bimatoprost was suspected, and the drug was discontinued, leading to the complete resolution of the choroidal detachment within 3 weeks in both eyes.. Choroidal detachment is a rare adverse effect which is not specific to bimatoprost but which has been also reported with the other prostaglandin analog drops. Its exact cause remains unclear, but is probably linked to the combination of enhanced uveoscleral outflow and pro-inflammatory properties. In all cases, the discontinuation of the prostaglandin analog led to the complete resolution of the choroidal detachment within 3 weeks.

    Topics: Administration, Ophthalmic; Administration, Topical; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Choroid Diseases; Cloprostenol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male

2012
Hypotony and choroidal detachment as a complication of travoprost after trabeculectomy surgery.
    Eye (London, England), 2008, Volume: 22, Issue:5

    Topics: Aged; Antihypertensive Agents; Choroid Diseases; Cloprostenol; Glaucoma; Humans; Intraocular Pressure; Male; Ocular Hypotension; Trabeculectomy; Travoprost

2008
Choroidal detachment after topical prostaglandin analogs: case report.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2005, Volume: 88, Issue:8

    To report three cases of delayed choroidal detachment after treatment with topical prostaglandin analogs.. Intervention three case reports. Four eyes of three patients with chronic angle closure glaucoma developed choroidal detachment after using topical prostaglandin analogs.. Three patients with chronic angle closure glaucoma developed chroidal detachment in one week, three weeks and two years after using travoprost, bimatoprost and latanoprost respectively. All of them resolved after discontinuation of these medications. All of the eyes that developed chroidal detachment were pseudophakic.. Travoprost, bimatoprost and latanoprost may lead to choroidal detachment and hypotony. Pseudophakic patients may be at high risk of the development of chroidal detachment. Topical prostaglandin analogs should be used cautiously in these patients.

    Topics: Administration, Topical; Aged; Amides; Bimatoprost; Choroid Diseases; Cloprostenol; Female; Glaucoma, Angle-Closure; Humans; Latanoprost; Lipids; Middle Aged; Ocular Hypotension; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Risk Factors; Time Factors; Travoprost

2005